AI Article Synopsis

  • The study investigates the potential of serum endothelin-1 levels as a noninvasive predictor for early esophageal rebleeding in patients with liver cirrhosis and portal hypertension.
  • Among 50 patients with acute esophageal variceal bleeding, those who experienced early rebleeding were found to have significantly different endothelin-1 and serum albumin levels compared to those who did not.
  • The findings suggest that a cutoff level of endothelin-1 at 65.29 can accurately predict rebleeding, highlighting its relevance as a clinical marker in managing these patients.

Article Abstract

Background/aims: Portal hypertension complicating liver cirrhosis is associated with vascular resistance, possibly due to overexpression of humoral vasoconstrictors, including endothelin. The study aimed to evaluate the efficacy of serum endothelin-1 levels as a noninvasive predictor of early esophageal rebleeding (within 5 days) following endoscopic treatment.

Materials And Methods: Of the patients presented to the endoscopy unit at Mansoura University Hospital, 50 patients were chosen for this study on the basis of endoscopically proven acute esophageal variceal bleeding consequent to hepatitis C viral infection complicated by liver cirrhosis and portal hypertension. Routine laboratory parameters and serum endothelin-1 levels were assessed prior to endoscopic treatment. Patients were divided into 2 groups depending on the development of early postendoscopic rebleeding. Group A consisted of 16 patients who developed rebleeding, while group B included 34 patients who did not. Statistical analysis was performed to determine the predictors of rebleeding.

Results: Multivariate logistic regression demonstrated that endothelin-1 level (P < .001) and serum albumin level (P = .04) were independent risk factors for early rebleeding. The most efficient cutoff value for endothelin-1 levels in predicting variceal rebleeding within the 5 days after endoscopic intervention was 65.29, which had an 88.2% specificity, 87.5% sensitivity, 88% accuracy, and area under the curve value of 0.89. In addition, hemoglobin, albumin, and creatinine levels were significantly different between bleeding and nonrebleeding groups (P = .03, P = .014, and P <.001, respectively), as was the duration of hospital stay (P < .001).

Conclusion: Serum endothelin-1 levels appear to be a reliable, practical, noninvasive predictor of early variceal rebleeding and related comorbidities such as the severity of kidney affection and duration of hospital stay.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895874PMC
http://dx.doi.org/10.5152/tjg.2024.23028DOI Listing

Publication Analysis

Top Keywords

endothelin-1 levels
16
esophageal variceal
8
variceal bleeding
8
portal hypertension
8
liver cirrhosis
8
serum endothelin-1
8
rebleeding days
8
days endoscopic
8
rebleeding group
8
patients
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!